Try our Advanced Search for more refined results

Braintree Laboratories, Inc. v. Novel Laboratories, Inc.

  1. November 12, 2014

    Braintree Asks High Court To Hear Claim Construction Row

    Braintree Laboratories Inc. has asked the U.S. Supreme Court to consider whether the Federal Circuit must defer to a district court's factual findings for claim construction, urging the justices to review its generic colon cleanser patent dispute, which it says hinges on the justices' forthcoming decision in Teva Pharmaceuticals USA v. Sandoz Inc.

  2. August 01, 2014

    Fed. Circ. Nixes Rehearing Bids In Colon Cleanser Patent Row

    The Federal Circuit on Friday flushed the rehearing bids of Braintree Laboratories Inc. and Novel Laboratories Inc. in their disputes over whether Novel's generic colon cleanser infringes a patent for Braintree's Suprep, according to a decision on Friday.

  3. July 21, 2014

    Braintree Says Suprep Case Doesn't Upend Drug Patent Law

    Braintree Laboratories Inc. has urged the full Federal Circuit to reject Novel Laboratories Inc.'s argument that a panel decision in the companies' patent dispute over the colon cleanser Suprep flouted drug patent law by holding that an unapproved use for a generic drug can infringe a patent.

  4. July 07, 2014

    Novel Fights 'Patient' Claim Rehearing In Suprep Suit

    Generic drug producer Novel Laboratories Inc. urged the Federal Circuit on Thursday to deny Braintree Laboratories Inc.'s bid for an en banc rehearing on the construction of the term "a patient" in its Suprep colon cleanser patent, saying the court properly rendered the claim to mean a "patient population."

  5. May 23, 2014

    Novel, Braintree Say Fed. Circ. Ruling Upends Hatch-Waxman

    A recent Federal Circuit decision in a patent infringement suit brought by Braintree Laboratories Inc. against Novel Laboratories Inc. over colon cleanser Suprep, has both sides this week calling for review of different aspects of the opinion they say could upset the natural order of the patent litigation landscape.

  6. April 22, 2014

    Fed. Circ. Flips Braintree Win In Generic Suprep Suit

    The Federal Circuit on Tuesday vacated a district court's ruling that Novel Laboratories Inc. infringed Braintree Laboratories Inc.'s patent for the colon cleanser Suprep, finding the lower court misconstrued a key claim term.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!